NCT05625984View on ClinicalTrials.gov

Study With Fascigel

NACompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

October 24, 2022

Primary Completion Date

November 13, 2023

Study Completion Date

November 13, 2023

Conditions
Back Pain
Interventions
DEVICE

Fascigel

The product is a Class III Medical Device. Structure is made by 1% sodium hyaluronate polysaccharide in normal saline solution.

Trial Locations (3)

602 00

Medicinecare s.r.o., Brno

100 34

FN Královské Vinohrady, Prague

150 06

FN Motol, Prague

Sponsors
All Listed Sponsors
lead

Contipro Pharma a.s.

OTHER

NCT05625984 - Study With Fascigel | Biotech Hunter | Biotech Hunter